Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011
SHENZHEN, China, Feb. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the fourth quarter ended December 31, 2010 after the U.S. market closes on February 28, 2011. Mindray's management will hold an earnings conference call at 8:00 AM on March 1, 2011 U.S. Eastern Time (9:00 PM on March 1, 2011 Beijing/Hong Kong Time).
Dial-in details for the earnings conference call are as follows:
Hong Kong: |
+852-3002-1672 |
|
U.S. Toll Free: |
+1-866-788-0538 |
|
International: |
+1-857-350-1676 |
|
Passcode for all regions: |
Mindray |
|
A replay of the conference call may be accessed by phone at the following numbers until March 15, 2011.
U.S. Toll Free: |
+1-888-286-8010 |
|
International: |
+1-617-801-6888 |
|
Passcode: |
6529 4305 |
|
Additionally, a live and archived webcast of this conference call will be available on the Investor Relations section of Mindray's website at http://ir.mindray.com.
About Mindray
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.
For investor and media inquiries please contact: |
|
In the U.S.: |
|
In China: |
|
SOURCE Mindray Medical International Limited
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article